Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi

European Journal of Immunology

Volumn 44, Issue 11, 2014, Pages 3192-3200

  Romani, Luigina ^a   Zelante, Teresa ^a   De Luca, Antonella ^a   Iannitti, Rossana G ^a   Moretti, Silvia ^a   Bartoli, Andrea ^a   Aversa, Franco ^b   Puccetti, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Aryl hydrocarbon receptor; IL 22; Indoleamine 2,3 dioxygenase 1; Microbiota; Mycobiome; Tryptophan

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; TRYPTOPHAN;

BIOSYNTHESIS; FUNGUS; HELPER CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LACTOBACILLUS; METABOLISM; MICROFLORA; MYCOSIS; PATHOGENICITY; REGULATORY T LYMPHOCYTE; SYMBIOSIS;

FUNGI; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERLEUKINS; LACTOBACILLUS; MICROBIOTA; MYCOSES; RECEPTORS, ARYL HYDROCARBON; SYMBIOSIS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TRYPTOPHAN;

EID: 84916887206     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344406     Document Type: Review

References (97)

1. Huffnagle, G. B. and Noverr, M. C., The emerging world of the fungal microbiome. Trends Microbiol. 2013. 21: 334-341.
2. Underhill, D. M. and Iliev, I. D., The mycobiota: interactions between commensal fungi and the host immune system. Nat. Rev. Immunol. 2014. 14: 405-416.
3. Ten Oever, J. and Netea, M.G., The bacteriome-mycobiome interaction and antifungal host defense. Eur. J. Immunol. 2014. 44: 3182-3191.
4. Romani, L., Immunity to fungal infections. Nat. Rev. Immunol. 2011. 11: 275-288.
5. Dupuy, A. K., David, M. S., Li, L., Heider, T. N., Peterson, J. D., Montano, E. A., Dongari-Bagtzoglou, A. et al., Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of malassezia as a prominent commensal. PLoS One 2014. 9: e90899.
6. Ghannoum, M. A., Jurevic, R. J., Mukherjee, P. K., Cui, F., Sikaroodi, M., Naqvi, A. and Gillevet, P. M., Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog 2010. 6: e1000713.
7. Morris, A. and Norris, K. A., Colonization by Pneumocystis jirovecii and its role in disease. Clin. Microbiol. Rev. 2012. 25: 297-317.
8. Cui, L., Morris, A. and Ghedin, E., The human mycobiome in health and disease. Genome. Med. 2013. 5: 63.
9. Findley, K., Oh, J., Yang, J., Conlan, S., Deming, C., Meyer, J. A., Schoenfeld, D. et al., Topographic diversity of fungal and bacterial communities in human skin. Nature 2013. 498: 367-370.
10. Bonifazi, P., Zelante, T., D'Angelo, C., De Luca, A., Moretti, S., Bozza, S., Perruccio, K., et al., Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol. 2009. 2: 362-374.
11. Iliev, I. D., Funari, V. A., Taylor, K. D., Nguyen, Q., Reyes, C. N., Strom, S. P., Brown, J. et al., Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 2012. 336: 1314-1317.
12. Schlapbach, C., Gehad, A., Yang, C., Watanabe, R., Guenova, E., Teague, J. E., Campbell, L. et al., Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity. Sci. Transl. Med. 2014. 6: 219ra218.
13. Kim, Y. G., Udayanga, K. G., Totsuka, N., Weinberg, J. B., Nunez, G. and Shibuya, A., Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE(2). Cell Host Microbe 2014. 15: 95-102.
14. Noverr, M. C., Noggle, R. M., Toews, G. B. and Huffnagle, G. B., Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 2004. 72: 4996-5003.
15. Ott, S. J., Kuhbacher, T., Musfeldt, M., Rosenstiel, P., Hellmig, S., Rehman, A., Drews, O. et al., Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand. J. Gastroenterol. 2008. 43: 831-841.
16. Mousset, S., Buchheidt, D., Heinz, W., Ruhnke, M., Cornely, O. A., Egerer, G., Kruger, W. et al., Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann. Hematol. 2014. 93: 13-32.
17. Romani, L. and Puccetti, P., Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol. 2006. 14: 183-189.
18. Peleg, A. Y., Hogan, D. A. and Mylonakis, E., Medically important bacterial-fungal interactions. Nat. Rev. Microbiol. 2010. 8: 340-349.
19. Wang, Z. K., Yang, Y. S., Stefka, A. T., Sun, G. and Peng, L. H., Review article: fungal microbiota and digestive diseases. Aliment. Pharmacol. Ther. 2014. 39: 751-766.
20. Sobel, J. D., Vulvovaginal candidosis. Lancet 2007. 369: 1961-1971.
21. Bukharin, O. V., Valyshev, A. V., Perunova, N. B., Chelpachenko, O. E., Mironova, A. R. and Trasevich, A. V., Bacterial-fungal associations in the intestine under the conditions of colonization by yeast-like fungi of the genus Candida. Zh. Mikrobiol. Epidemiol. Immunobiol. 2002. 5: 45-48.
22. Smeekens, S. P., Huttenhower, C., Riza, A., van de Veerdonk, F. L., Zeeuwen, P. L., Schalkwijk, J., van der Meer, J. W. et al., Skin Microbiome Imbalance in Patients with STAT1/STAT3 Defects Impairs Innate Host Defense Responses. J. Innate Immun. 2014. 6: 253-262.
23. Lanternier, F., Cypowyj, S., Picard, C., Bustamante, J., Lortholary, O., Casanova, J. L. and Puel, A., Primary immunodeficiencies underlying fungal infections. Curr. Opin. Pediatr. 2013. 25: 736-747.
24. Shenderov, B. A., Metabiotics: novel idea or natural development of probiotic conception. Microb. Ecol. Health Dis. 2013. 24: 20399.
25. Casadevall, A. and Pirofski, L. A., The damage-response framework of microbial pathogenesis. Nat. Rev. Microbiol. 2003. 1: 17-24.
26. Rappleye, C. A., Eissenberg, L. G. and Goldman, W. E., Histoplasma capsulatum alpha-(1, 3)-glucan blocks innate immune recognition by the beta-glucan receptor. Proc. Natl. Acad. Sci. U. S. A. 2007. 104: 1366-1370.
27. Aimanianda, V., Bayry, J., Bozza, S., Kniemeyer, O., Perruccio, K., Elluru, S. R., et al., Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 2009. 460: 1117-1121.
28. Tsitsigiannis, D. I. and Keller, N. P., Oxylipins as developmental and host-fungal communication signals. Trends Microbiol. 2007. 15: 109-118.
29. Kroger, S., Neuber, K., Gruseck, E., Ring, J. and Abeck, D., Pityrosporum ovale extracts increase interleukin-4, interleukin-10 and IgE synthesis in patients with atopic eczema. Acta Derm. Venereol. 1995. 75: 357-360.
30. Hooper, L. V., Littman, D. R. and Macpherson, A. J., Interactions between the microbiota and the immune system. Science 2012. 336: 1268-1273.
31. Zelante, T., Iannitti, R. G., De Luca, A., Arroyo, J., Blanco, N., Servillo, G., Sanglard, D. et al., Sensing of mammalian IL-17A regulates fungal adaptation and virulence. Nat. Commun. 2012. 3: 683.
32. Kumamoto, C. A., Inflammation and gastrointestinal Candida colonization. Curr. Opin. Microbiol. 2011. 14: 386-391.
33. Gerard, R., Sendid, B., Colombel, J. F., Poulain, D. and Jouault, T., An immunological link between Candida albicans colonization and Crohn's disease. Crit. Rev. Microbiol. 2013. In press. doi: 10.3109/1040841X.2013.810587.
34. Ramirez-Garcia, A., Rementeria, A., Aguirre-Urizar, J. M., Moragues, M. D., Antoran, A., Pellon, A., Abad-Diaz-de-Cerio, A. et al., Candida albicans and cancer: can this yeast induce cancer development or progression? Crit. Rev. Microbiol. 2014. 25: 1-13.
35. Kekki, O. M., Scheynius, A., Poikonen, S., Koskinen, A., Kautiainen, H. and Turjanmaa, K., Sensitization to Malassezia in children with atopic dermatitis combined with food allergy. Pediatr. Allergy Immunol. 2013. 24: 244-249.
36. Gaitanis, G., Magiatis, P., Hantschke, M., Bassukas, I. D. and Velegraki, A., The Malassezia genus in skin and systemic diseases. Clin. Microbiol. Rev. 2012. 25: 106-141.
37. Stone, T. W. and Darlington, L. G., Endogenous kynurenines as targets for drug discovery and development. Nat. Rev. Drug Discov. 2002. 1: 609-620.
38. Metz, R., Duhadaway, J. B., Kamasani, U., Laury-Kleintop, L., Muller, A. J. and Prendergast, G. C., Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2, 3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 2007. 67: 7082-7087.
39. Murray, M. F., The human indoleamine 2, 3-dioxygenase gene and related human genes. Curr. Drug Metab. 2007. 8: 197-200.
40. Zelante, T., Fallarino, F., Bistoni, F., Puccetti, P. and Romani, L., Indoleamine 2, 3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host. Microbes Infect. 2009. 11: 133-141.
41. Pfefferkorn, E. R., Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. U. S. A. 1984. 81: 908-912.
42. Fallarino, F., Grohmann, U. and Puccetti, P., Indoleamine 2, 3-dioxygenase: from catalyst to signaling function. Eur. J. Immunol. 2012. 42: 1932-1937.
43. Munn, D. H. and Mellor, A. L., Indoleamine 2, 3 dioxygenase and metabolic control of immune responses. Trends Immunol. 2013. 34: 137-143.
44. McGaha, T. L., Huang, L., Lemos, H., Metz, R., Mautino, M., Prendergast, G. C. and Mellor, A. L., Amino acid catabolism: a pivotal regulator of innate and adaptive immunity. Immunol. Rev. 2012. 249: 135-157.
45. Zhang, Y. J., Reddy, M. C., Ioerger, T. R., Rothchild, A. C., Dartois, V., Schuster, B. M., Trauner, A. et al., Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing. Cell 2013. 155: 1296-1308.
46. Pallotta, M. T., Orabona, C., Volpi, C., Vacca, C., Belladonna, M. L., Bianchi, R., Servillo, G., et al., Indoleamine 2, 3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat. Immunol. 2011. 12: 870-878.
47. Grohmann, U., Volpi, C., Fallarino, F., Bozza, S., Bianchi, R., Vacca, C., Orabona, C. et al., Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat. Med. 2007. 13: 579-586.
48. Romani, L., Zelante, T., De Luca, A., Fallarino, F. and Puccetti, P., IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J. Immunol. 2008. 180: 5157-5162.
49. Wuthrich, M., Deepe, G. S., Jr. and Klein, B., Adaptive immunity to fungi. Annu. Rev. Immunol. 2012. 30: 115-148.
50. Puel, A., Cypowyj, S., Marodi, L., Abel, L., Picard, C. and Casanova, J. L., Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr. Opin. Allergy Clin. Immunol. 2012. 12: 616-622.
51. Ouederni, M., Sanal, O., Ikinciogullari, A., Tezcan, I., Dogu, F., Sologuren, I., Pedraza-Sanchez, S. et al., Clinical features of Candidiasis in patients with inherited interleukin 12 receptor beta1 deficiency. Clin. Infect. Dis. 2014. 58: 204-213.
52. Singh, N. and Perfect, J. R., Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect. Dis. 2007. 7: 395-401.
53. Yuasa, H. J. and Ball, H. J., Indoleamine 2, 3-dioxygenases with very low catalytic activity are well conserved across kingdoms: IDOs of Basidiomycota. Fungal Genet. Biol. 2013. 56: 98-106.
54. Stockinger, B., Di Meglio, P., Gialitakis, M. and Duarte, J. H., The aryl hydrocarbon receptor: multitasking in the immune system. Annu. Rev. Immunol. 2014. 32: 403-432.
55. McMillan, B. J. and Bradfield, C. A., The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems. Mol. Pharmacol. 2007. 72: 487-498.
56. Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M. et al., Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008. 453: 65-71.
57. Lee, J. S., Cella, M., McDonald, K. G., Garlanda, C., Kennedy, G. D., Nukaya, M., Mantovani, A. et al., AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 2012. 13: 144-151.
58. Qiu, J., Heller, J. J., Guo, X., Chen, Z. M., Fish, K., Fu, Y. X. and Zhou, L., The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 2012. 36: 92-104.
59. Teunissen, M. B., Munneke, J. M., Bernink, J. H., Spuls, P. I., Res, P. C., Te Velde, A., Cheuk, S. et al., Composition of innate lymphoid cell (ILC) subsets in the human skin: enrichment of ncr ilc3 in lesional skin and blood of psoriasis patients. J. Invest. Dermatol. 2014.
60. Sonnenberg, G. F., Fouser, L. A. and Artis, D., Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 2011. 12: 383-390.
61. Behnsen, J., Jellbauer, S., Wong, C. P., Edwards, R. A., George, M. D., Ouyang, W. and Raffatellu, M., The Cytokine IL-22 Promotes Pathogen Colonization by Suppressing Related Commensal Bacteria. Immunity 2014. 40: 262-273.
62. Zenewicz, L. A., Yin, X., Wang, G., Elinav, E., Hao, L., Zhao, L. and Flavell, R. A., IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J. Immunol. 2013. 190: 5306-5312.
63. Zelante, T., Iannitti, R. G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R. et al., Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013. 39: 372-385.
64. Qiu, J., Guo, X., Chen, Z. M., He, L., Sonnenberg, G. F., Artis, D., Fu, Y. X. et al., Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity 2013. 39: 386-399.
65. Nguyen, L. P. and Bradfield, C. A., The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 2008. 21: 102-116.
66. Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C. et al., The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 2006. 176: 6752-6761.
67. Lowe, M. M., Mold, J. E., Kanwar, B., Huang, Y., Louie, A., Pollastri, M. P., Wang, C. et al., Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production. PLoS One 2014. 9: e87877.
68. Mezrich, J. D., Fechner, J. H., Zhang, X., Johnson, B. P., Burlingham, W. J. and Bradfield, C. A., An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 2010. 185: 3190-3198.
69. Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T. et al., An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 2011. 478: 197-203.
70. Bessede, A., Gargaro, M., Pallotta, M. T., Matino, D., Servillo, G., Brunacci, C., Bicciato, S. et al., Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 2014. 511: 184-190.
71. Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C. and Siuzdak, G., Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. U. S. A 2009. 106: 3698-3703.
72. Heath-Pagliuso, S., Rogers, W. J., Tullis, K., Seidel, S. D., Cenijn, P. H., Brouwer, A. and Denison, M. S., Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry 1998. 37: 11508-11515.
73. Di Meglio, P., Duarte, J. H., Ahlfors, H., Owens, N. D., Li, Y., Villanova, F., Tosi, I. et al., Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity 2014. 40: 989-1001.
74. Esser, C., Bargen, I., Weighardt, H., Haarmann-Stemmann, T. and Krutmann, J., Functions of the aryl hydrocarbon receptor in the skin. Semin Immunopathol 2013. 35: 677-691.
75. Gaitanis, G., Magiatis, P., Stathopoulou, K., Bassukas, I. D., Alexopoulos, E. C., Velegraki, A. and Skaltsounis, A. L., AhR ligands, malassezin, and indolo[3, 2-b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis. J. Invest. Dermatol. 2008. 128: 1620-1625.
76. Vlachos, C., Schulte, B. M., Magiatis, P., Adema, G. J. and Gaitanis, G., Malassezia-derived indoles activate the aryl hydrocarbon receptor and inhibit Toll-like receptor-induced maturation in monocyte-derived dendritic cells. Br. J. Dermatol. 2012. 167: 496-505.
77. Aldridge, B. B. and Rhee, K. Y., Microbial metabolomics: innovation, application, insight. Curr. Opin. Microbiol. 2014. 19C: 90-96.
78. Hashimoto, T., Perlot, T., Rehman, A., Trichereau, J., Ishiguro, H., Paolino, M., Sigl, V. et al., ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 2012. 487: 477-481.
79. Redman, S., Webb, G. R., Oak, S. and Sanson-Fisher, R. W., Drug research: a comparison of ongoing research and perceived research priorities. Br. J. Addict. 1990. 85: 943-952.
80. Oh, S., Go, G. W., Mylonakis, E. and Kim, Y., The bacterial signalling molecule indole attenuates the virulence of the fungal pathogen Candida albicans. J. Appl. Microbiol. 2012. 113: 622-628.
81. Zelante, T., Iannitti, R., De Luca, A. and Romani, L., IL-22 in antifungal immunity. Eur. J. Immunol. 2011. 41: 270-275.
82. Liu, Y., Yang, B., Zhou, M., Li, L., Zhou, H., Zhang, J., Chen, H. and Wu, C., Memory IL-22-producing CD4+ T cells specific for Candida albicans are present in humans. Eur. J. Immunol. 2009. 39: 1472-1479.
83. Eyerich, K., Eyerich, S., Hiller, J., Behrendt, H. and Traidl-Hoffmann, C., Chronic mucocutaneous candidiasis, from bench to bedside. Eur. J. Dermatol. 2010. 20: 260-265.
84. De Luca, A., Carvalho, A., Cunha, C., Iannitti, R. G., Pitzurra, L., Giovannini, G., Mencacci, A. et al., IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis. PLoS Pathog. 2013. 9: e1003486.
85. Guo, X., Qiu, J., Tu, T., Yang, X., Deng, L., Anders, R. A., Zhou, L. et al., Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity 2014. 40: 25-39.
86. Lievin-Le Moal, V. and Servin, A. L., Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clin. Microbiol. Rev. 2014. 27: 167-199.
87. Karczewska, E., Wojtas, I., Sito, E., Trojanowska, D., Budak, A., Zwolinska-Wcislo, M. and Wilk, A., Assessment of co-existence of Helicobacter pylori and Candida fungi in diseases of the upper gastrointestinal tract. J. Physiol. Pharmacol. 2009. 60(Suppl 6): 33-39.
88. Tannock, G. W. and Savage, D. C., Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract. Infect. Immun. 1974. 9: 591-598.
89. Denou, E., Berger, B., Barretto, C., Panoff, J. M., Arigoni, F. and Brussow, H., Gene expression of commensal Lactobacillus johnsonii strain NCC533 during in vitro growth and in the murine gut. J. Bacteriol. 2007. 189: 8109-8119.
90. Walter, J., Britton, R. A. and Roos, S., Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proc. Natl. Acad. Sci. USA 2011. 108(Suppl 1): 4645-4652.
91. Tannock, G. W., Wilson, C. M., Loach, D., Cook, G. M., Eason, J., O'Toole, P. W., Holtrop, G. et al., Resource partitioning in relation to cohabitation of Lactobacillus species in the mouse forestomach. ISME J 2012. 6: 927-938.
92. Elmer, G. W., Surawicz, C. M. and McFarland, L. V., Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 1996. 275: 870-876.
93. Lutgendorff, F., Akkermans, L. M. and Soderholm, J. D., The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Curr. Mol. Med. 2008. 8: 282-298.
94. Sjogren, Y. M., Tomicic, S., Lundberg, A., Bottcher, M. F., Bjorksten, B., Sverremark-Ekstrom, E. et al., Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin. Exp. Allergy 2009. 39: 1842-1851.
95. Manzoni, P., Mostert, M., Leonessa, M. L., Priolo, C., Farina, D., Monetti, C., Latino, M. A. et al., Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin. Infect. Dis. 2006. 42: 1735-1742.
96. Jenq, R. R., Ubeda, C., Taur, Y., Menezes, C. C., Khanin, R., Dudakov, J. A., Liu, C. et al., Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J. Exp. Med. 2012. 209: 903-911.
97. De Luca, A., Zelante, T., D'Angelo, C., Zagarella, S., Fallarino, F., Spreca, A., Iannitti, R. G. et al., IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 2010. 3: 361-373.